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Abstract Beneficial microbes, such as lactobacilli establish a
symbiosis with the host and confer health-associated effects,
by limiting the growth of indigenous pathogens and challeng-
ing microbes introduced by altered foods. Nevertheless, there
is scarce information on the effects of beneficial microbes on
the virulence properties of bacterial species associated
with oral diseases, such as periodontitis. Aggregatibacter
actinomycetemcomitans is a Gram-negative species highly
implicated in the etiology of localized aggressive periodonti-
tis. The objective of this study was to investigate the effect of
lactobacilli on the expression of the two major virulence
factors ofA. actinomycetemcomitans. Lactobacillus salivarius
and L. gasseri were selected as beneficial species. The gene
expressions of leukotoxin (LtxA) and cytolethal distending
toxin (CdtB) by A. actinomycetemcomitans were analyzed in
response to challenge by lactobacilli cell-free supernatants.
Neither lactobacilli affected the growth, but strongly attenuat-
ed the expressions of both CdtB and LtxA in the two A.
actinomycetemcomitans strains tested. This reduction of the
expression of these two exotoxins was time-dependent. These
fundamental findings may indicate that lactobacilli can reduce
the virulence of putative opportunistic oral pathogens, and
may provide insights to future therapeutic approaches for the
respective diseases.
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Introduction
Microbial ecology has now entered the microbiome era,
which is the systemic study of a microbial community as a
functional entity (Chen et al. 2010). The Human Microbiome
Project of the United States National Institute of Health has set
the basis (Turnbaugh et al. 2007), while the Human Oral
Microbiome Database (Chen et al. 2010), in particular, is
investigating in further detail the specialized ecological niche
of the oral cavity. The oral microbiome is one of the most
studied in humans, due to the easy accessibility of bacterial
samples, and the fact that some species are associated with
very frequent human infections with vast socio-economical
implications, such as periodontal diseases and dental caries,
but also because respiratory and intestinal pathogens
may access the respective systems via the oral cavity
(Raghavendran et al. 2007; Kuehbacher et al. 2008). Recent
evidence demonstrates that the oral cavity hosts approximately
700 prevalent bacterial taxa, with distinct subsets predominating
at different habitats (Dewhirst et al. 2010). Nevertheless, not
much is known about the related molecular cross-talk and
ecological interactions within these habitats. In this respect,
a number of studies have investigated host–microbe interac-
tions (Handfield et al. 2005; Hasegawa et al. 2007;
Belibasakis et al. 2011a, b), whereas others have focused on
the intimate challenge between antagonistic microbial species
(Ishikawa et al. 2003). Among these microbes, some take part
in disease, while others contribute to maintenance of health
(Lazarevic et al. 2009). In principle, the latter could control the
virulence of former by specific strategies such as competitive
exclusion or displacement. Beneficial bacteria possess differ-
ent capacities aiming at limiting the growth of neighboring
pathogens. For example, bacterial products like bacteriocins
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can exert antimicrobial activity, or even perturb the local
microenvironment, by modulating the pH or O2 content,
which would in turn result inhibition of certain pathogens.
The disruption of a proper mutualism between commensals
and pathogens within a microbial consortium can facilitate the
onset of local infections and diseases. Such examples are peri-
odontal diseases and dental caries, which are the most common
oral diseases, and among the most prevalent infections in
humans.While putative oral pathogens are well described, there
is scarce information over the potential oral health-promoting
role of indigenous commensals, such as lactobacilli that are
reported as beneficial species in other ecological niches, and
even used as probiotics supplements. Aggregatibacter
actinomycetemcomitans is a Gram-negative facultatively anaer-
obic opportunistic oral pathogen, which is highly implicated in
the etiology of aggressive periodontitis (Henderson et al. 2010;
Haubek 2010). The disease is characterized by rapid disease
of the tooth-supporting (periodontal) tissues, and affects
adolescents and young adults. The main virulence factors
of A. actinomycetemcomitans are the leukotoxin and the
cytolethal distending toxin (Cdt), which are protein exo-
toxins targeting cells of the immune system or the peri-
odontal tissues. The Cdt can cause growth inhibition and
eventually apoptosis to virtually all eukaryotic cells, where-
as the leukotoxin can selectively kill human leukocytes, or
activate them to produce a strong pro-inflammatory re-
sponse (Fine et al. 2006). The objective of the present study
was to investigate the effect of secreted lactobacilli prod-
ucts on the gene expression of these two virulence factors
(namely LtxA and CdtB) by A. actinomycetemcomitans in
planktonic culture. The hypothesis is that the beneficial
species, lactobacilli in this case, could be able to attenuate
or inhibit the expression of the investigated virulence factor
genes. This approach may enlighten the relationship(s)
between putative periodontal pathogens and lactobacilli
that can reside in the oral cavity, with known probiotic
capacity for the health of the gastro-intestinal tract (GIT).
It may also provide clearer insights to future adjunctive
therapeutic approaches for the treatment of periodontitis.
Materials and methods
Microbial strains and products
Aggregatibacter actinomycetemcomitans OMZ250b (Y4
clone) and OMZ295 (JP2 clone), Lactobacillus salivarius
OMZ520 and L. gasseri OMZ525 were obtained from the
OMZ culture collection of the Section of Oral Microbiology
and Immunology, University of Zürich. Bacteria were cultured
on modified Fluid Universal Medium (mFUM) (Guggenheim
et al. 2001) under aerobic conditions and 10 % CO2 (HeraCell
240, Heraeus; ThermoFisher Scientific, Bremen, Germany).
Per liter of distilled water, mFUM contained 10 g tryptone, 5 g
yeast extract, 3 g glucose, 2 mg hemin, 1 mgmenadione, 0.5 g
cysteine hydrochloride, 2 g NaCl, 0.5 g Na2CO3, 1 g KNO3,
0.9 g K2HPO4, 0.9 g of (NH4)2SO4, and 0.18 g MgSO4·7H20,
supplemented with 67 mmol Sorensen’s buffer, at a pH of 7.2.
A. actinomycetemcomitans strains OMZ250b (Y4 clone) and
OMZ295 (JP2 clone) used in this study were cultured in
mFUM supplemented with 0.3 % glucose at 37 °C for 48 h.
L. salivarius OMZ520 and L. gasseri OMZ525 were also
cultured in mFUM, which was instead supplemented with
0.15 % glucose and 0.15 % sucrose at 37 °C for 24 h. The
density of each bacterial strain in culture was quantified with a
spectrophotometer at OD600 (U 2000, Hitachi; Boehringer-
Mannheim, Rotkreuz, Switzerland) and CFU/ml were defined
by plotting the OD against an established bacterial growth
curve. After a 24-h period of growth, the lactobacilli suspen-
sion cultures were harvested, their density was measured, and
the cultures were thereafter centrifuged. The cell pellet was
discarded and the cell-free supernatants were then buffered
with a 10 % v/v of PBS (pH 7), filter-sterilized (0.22 μm)
before being used in the experimentations with A. actinomy-
cetemcomitans at dilutions corresponding to lactobacilli con-
centrations of 104 CFU/ml.
Microbial interactions
Aggregatibacter actinomycetemcomitans strain OMZ295 or
OMZ250b cultures in the exponential growth phase were used
at a concentration of 107 CFU/ml. These were cultured in
fresh mFUM, in the presence or absence of 104 CFU/ml
lactobacilli cell-free supernatants (10 % v/v). After 3 and 6 h
of incubation, bacterial density was quantified at OD600, and
the A. actinomycetemcomitans bacterial cells in culture were
harvested by centrifugation, and their total RNA content was
isolated.
RNA isolation and cDNA synthesis
Cells were lysed with 400 μg/ml of Lysozyme in TE solution,
at room temperature for 10 min. RNA was isolated with
RNeasy mini kit and Bacteria Protect reagent (Qiagen,
Hilden, Germany). RNAyield and purity was determinedwith
a NanoDrop spectophotometer (ThermoFisher Scientific).
The isolated total RNA samples exhibited a λ260/λ280 be-
tween 1.8 and 2.2. This was then reversed transcribed into
cDNA, by using Moloney murine leukemia virus reverse-
transcriptase enzyme (M-MLV RT RNase H minus)
(Promega, Madison, Wi, USA). Briefly, 1 μg of total RNA
was incubated with 0.5 μg/ml of Oligo(dT)15 primer
(Promega) at 70 °C for 5 min and cooled on ice. A master
mix was added to the samples, comprising 10 mM dNTPs,
200 units of M-MLV RT enzyme and buffer (Promega), and
nuclease-free water to a final volume of 25μl. For the reverse-
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transcription reaction, these samples were incubated at 40 °C
for 60 min, 70 °C for 15 min, and cooled to 4 °C on a PCR
apparatus (Biometra, Goettingen, Germany). The products
obtained were then stored at −20 °C until further analysis by
qPCR for relative quantification of gene expression.
Quantitative real time polymerase chain reaction (qPCR)
Gene expressions of CdtB subunit of Cdt, LtxA subunit for
leukotoxin and GlyA (glycine/serine hydroxymethyl transfer-
ase A) for the endogenous control were analyzed using an
ABI Prism7000 Sequence Detection System (Applied
Biosystems, Foster City, CA, USA), and coupled with
SYBR Green Master Mix (Applied Biosystems). The CdtB
gene oligonucleotide primers were designed using Primers
Express 3.0 software (Applied Biosystems) and the sequences
were: forward: 5′-GGGCAAACCGAGTGAACTTA-3′, and
reverse: 5′-CTCGTCTTTCCGGTGATGAT-3′. Primers se-
quences for LtxA and GlyA endogenous control were
obtained from the literature. For GlyA gene, the sequences
were: forward: 5′-CCCAATTCACCAACAAATATGC-3′,
and reverse: 5′-ATTCTTTCGCACGCTCAATAG-3′ (Isaza
et al. 2008). For the LtxA gene, the sequences were: forward:
5′-GTGCTAGGTAAACATCGGTAAAG-3′, and reverse 5′-
GACCACAGAGGCAATTAACC-3′ (Isaza et al. 2008).
Before proceeding to the quantification reactions, the
specificity of each primer pair was evaluated with the
melt-curve analysis software of the Prism7000 Sequence
Detection System (Applied Biosystems). The selected
primers pairs showed no nonspecific peaks. Calculation
of expression values for each gene was performed by
the 2-ΔCt method, calibrated against the expression of
GlyA endogenous control that was found to be consis-
tently expressed under all conditions. Cycle threshold is
abbreviated as Ct and the ΔCt calculation was as
follows: Ct (+RT)−Ct (−RT)=cCt (corrected CT).
ΔCt=cCt(targetgene)−cCt(endogenouscontrolgene,GlyA)
(Belibasakis et al. 2011a, b).
Statistic analysis
Experiments were performed at least three times to
ensure reproducibility of results. The results are reported
as means±standard deviations (SD). A two-way ANOVA
followed by Tukey’s test were used for statistical compari-
sons, and P<0.05 was considered statistically significant.
Results
The growth of A. actinomycetemcomitans was not inhibited
when cultured in the presence of cell-free lactobacilli culture
supernatants, over the 6-h experimental period (Table 1).
Nevertheless, the expression of CdtB and LtxA genes was
attenuated in both A. actinomycetemcomitans strains, when
cultured in the presence of lactobacilli cell-free supernatants.
Supernatants from both L. salivarius and L. gasseri were
capable to down-regulate CdtB and LtxA gene expressions,
but in different manners.
Relative expression of CdtB subunit
The attenuation of CdtB gene expression of A. actinomy-
cetemcomitans OMZ295 (Fig. 1) was evident at 3 h, and
mainly when exposed to L. salivarius supernatant. At this
early time-point, L. salivarius significantly down-regulated
CdtB expression by more than 4-fold compared to the control.
On the other hand, L. gasseri was slightly less potent in this
effect, by causing a less than 3-fold down-regulation, in com-
parison to the respective control. This attenuation of CdtB
expression was maintained over 6 h in the presence of L.
salivarius, but partly resumed the levels of the untreated A.
actinomycetemcomitans control in the presence of L. gasseri.
In the case of A. actinomycetemcomitans strain OMZ250b,
both L. gasseri and L. salivarius supernatants inhibited CdtB
expression as early as 3 h, by approximately 3-fold compared
to the control (Fig. 1). After 6 h, the attenuation of CdtB
expression was persistent in the presence of either L.
salivarius or L. gasseri, which was in both cases more than
2-fold lower compared to the control.
Relative expression of the LtxA subunit
The expression of LtxAwas further investigated. In the case of
A. actinomycetemcomitans strain OMZ295, LtxA expression
was already reduced at 3 h in the presence of L. salivarius
compared to the untreated control, and this attenuation was
Table 1 Growth of A. actinomycetemcomitans strain OMZ250b and
OMZ295 for up to 6 h in the presence of lactobacilli cell-free culture
supernatants
Strain Bacterial growth at OD600




+ L. salivarius OMZ 520 0.4 0.45±0.014 0.645±0.007




+ L. salivarius OMZ 520 0.4 0.45±0.015 0.615±0.014
+ L. gasseri OMZ 525 0.4 0.44±0.007 0.525±0.049
a Starting bacterial inoculum.
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maintained over 6 h (Fig. 2). On the contrary, in the
presence of L. gasseri, LtxA expression was not signif-
icantly affected after 3 h, but at 6 h this was signifi-
cantly down-regulated compared to the control, and to a
similar extent as in the case of L. salivarius (Fig. 2).
The effect of lactobacilli supernatants on LtxA expres-
sion was also investigated in A. actinomycetemcomitans
strain OMZ250b. LtxA expression in this strain after 3 h was
already significantly down-regulated in the presence of either
lactobacilli species, and this effect persisted over 6 h
(Fig. 2). L. gasseri was more potent than L. salivarius
in attenuating LtxA expression, particularly after 3 h of
A. actinomycetemcomitans OMZ250b culture.
Discussion
The ability of lactobacilli and other lactic acid bacteria (LAB)
to colonize the oral cavity and in particular the periodontium is
still debated. Some lactobacilli are indigenous and inhabit the
oral cavity of the newborn as they are transferred from the
mother (e.g., Lactobacillus vaginalis and the bifidobacteria
Fig. 1 Effect of lactobacilli cell-










controls, at the corresponding
time-points
Fig. 2 Effect of lactobacilli cell-







to the untreated A.
actinomycetemcomitans
OMZ295 and OMZ250b
controls, respectively, at the
corresponding time-points
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group). This phenomenon is not restricted to the oral cavity,
but is generalized to the whole human body. As happens for
the GIT, the skin, and for several mucosas, the first bacteria to
settle and colonize these niches are mainly bifidobacteria, but
even include lactobacilli and other LAB species.Most of these
are considered probiotic, or at least not harmful, commensals.
This study aimed to identify if oral lactobacilli, with prov-
en probiotic capability in the GIT, are able to attenuate or
inhibit the gene expression of the two major exotoxins
(virulence factors) of the putative periodontal pathogen
A. actinomycetemcomitans. The selection of L. salivarius
and L. gasseri as putative oral probiotics was justified by
their detection in the composition of the microbiota of the
periodontium, primarily at healthy sites, compared to sites
affected by periodontitis (Koll-Klais et al. 2005; Hojo
et al. 2007; Badet and Thebaud. 2008; Pham et al. 2009).
Concerning L. salivarius, there are reports proposing that
this species could act as putative probiotic for the
periodontium (Shimauchi et al. 2008; Mayanagi et al.
2009; Iwamoto et al. 2010). To date, considering the lim-
ited number of papers dealing with this issue, L. salivarius
is perhaps the best characterized indigenous putative pro-
biotic species inhabiting the oral cavity. While some au-
thors have reviewed and supported the health benefits of
probiotics in the oral cavity (Meurman and Stamatova.
2007; Stamatova and Meurman. 2009), it is of interest to
mention that some studies have described lactobacilli
(Mantzourani et al. 2009a, b), and in particular L.
salivarius, in association with caries (Matsumoto et al.
2005). Another study has shown in an in vitro model that
L. salivarius decreased the numbers of black pigmented
anaerobic rods that are associated with periodontitis
(Ishikawa et al. 2003). Notwithstanding, there are no stud-
ies on the molecular cross-talk between lactobacilli or their
products on the virulence mechanisms of putative oral
pathogens. Lactobacillus gasseriwas selected for the pres-
ent experimental system mainly based on recent findings
that outlined this species as one of the most potent among a
set of new isolates of putative probiotic/beneficial bacteria
(Nissen et al. 2009; Kawase et al. 2011). Considering all
these aspects, to our knowledge the present study is one of
the first that has addressed the effects of lactobacilli on the
expression of virulence factors of any putative oral patho-
gen. Both lactobacilli species tested in this study demon-
strated promising results in competition with the putative
periodontal pathogen A. actinomycetemcomitans. The at-
tenuation of gene expression of the two toxins appears to
be visible as early as 3 h, and is not commensurate with a
reduction of A. actinomycetemcomitans growth. The effect
on LtxA expression appeared to be more time-dependent than
that on CdtB expression. The present results also demonstrate
that both of the tested A. actinomycetemcomitans strains,
namelyOMZ250b (which is a Y4 clone) and OMZ295 (which
is a JP2 clone), are sensitive to the presence of lactobacilli
supernatants, even though the JP2 clone generally exhibits
higher toxin activity than the Y4 clone (Kawamoto et al.
2009).
The ecological complexity of the oral cavity environment
is partly attributed to interrelationships between different spe-
cies (i.e. synergistic or antagonistic), which are subject to
changes due to food intake and diet habits. Indeed, the oral
microbiome is in constant exposure to the products of the cud,
which can directly affect its ecology. In this complex environ-
ment, an equilibrium ratio of beneficial and pathogenic mi-
crobes is essential: to prevent the establishment of dental
caries or periodontal diseases, and to potentially reduce the
emanation of bacterial toxins further distally into the GIT. The
mechanism by which the cell-free supernatants of the
lactobacilli tested are able to affect mRNA expression of A.
actinomycetemcomitans virulence factors is unknown.
Nevertheless, the present findings that lactobacilli at densities
as low as 104 CFU/ml can elicit an adequate effect on reducing
the expressions of leukotoxin and Cdt is encouraging, since it
demonstrates that a high probiotic load is not necessary for
potential therapies. It is otherwise well documented that LAB
species are able to produce a class of molecules with antimi-
crobial capability. For instance, bacteriocins produced by L.
gasseri are able to inhibit enteric pathogens (Itoh et al. 1995;
Alpay Karaoglu et al. 2003). Moreover, bacteriocins produced
by L. salivarius are able to inhibit the growth of clinical
Staphylococcus aureus isolates (Robredo and Torres. 2000),
as well as Listeria monocytogenens (Corr et al. 2007). The
effect of this class of molecules and other antimicrobial factors
produced by lactobacilli is inhibitory against bacterial patho-
gens at a certain dosage, but the effect of minimal doses
remains unclear. Recently, it was reported that sub-lethal dos-
age of different antimicrobials could down-regulate the expres-
sion of virulence genes of bacterial pathogens, such as Vibrio
cholerae (Chatterjee et al. 2010; Yamasaki et al. 2011) and
Staphylococcus aureus (Smith-Palmer et al. 2004; Qiu et al.
2011), without inhibiting their growth. This action could
reflect the effects observed in the present work in A.
actinomycetemcomitans.
The results obtained in this study indicate that probiotic
species (i.e. lactobacilli) may reduce the virulence capacities of
putative oral pathogens, at least as judged by the effects on A.
actinomycetemcomitans. This observation could be useful to
produce an application able to control or eradicate the presence
of putative periodontal pathogens in the periodontium. The
possibility to manage oral diseases with a natural, non-invasive
and non-stressful method is particularly appealing, and may
prevent problems related to pharmacological treatments, such
Ann Microbiol (2014) 64:611–617 615
as the use of antibiotics. Last, but not least, the use of cell-free
supernatants instead of viable bacteria is an added value forwider
and easier application, particularly for these diseases embracing
the immune system in order to prevent the continuous antigenic
load.
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